NeuExcell Therapeutics Raises $10+ Million Series Pre-A Round To Continue Its Company Growth ...Middle East

PR Newswire - News
NeuExcell Therapeutics Raises $10+ Million Series Pre-A Round To Continue Its Company Growth
STATE COLLEGE, Pa., Aug. 30, 2021 /PRNewswire/ -- NeuExcell Therapeutics (www.neuexcell.com), a gene therapy company focusing on neurodegenerative diseases, has announced a $10+ million Series Pre-A financing round. The round was led by Co-Win Ventures, joined by other institutional...

Read More Details
Finally We wish PressBee provided you with enough information of ( NeuExcell Therapeutics Raises $10+ Million Series Pre-A Round To Continue Its Company Growth )

Apple Storegoogle play

Also on site :